Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP ®, the world’s first digitally printed single-point midline oral appliance device for sleep apnea.

Vivos Therapeutics, Inc. has announced that its VidaSleep™ oral appliance, equipped with FDA-cleared Unilateral Bite Block technology, has received approval from the Centers for Medicare & Medicaid ...

Cardiovascular benefits and harms could be detected with continuous positive airway pressure (CPAP) treatment for select patients with obstructive sleep apnea (OSA), a pooled analysis of major ...

2. Assess the patient’s response to therapy. Follow-up assessments are essential to identifying potential barriers to effective therapy, optimizing the therapeutic response, achieving better outcomes, ...

In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive sleep apnea and cardiovascular disease. However, CPAP leaned toward benefit ...